Roberto Iacone, Roche, Discusses the Use of Stem Cells in Diabetic Cardiomyopathy Research
 19 March 2014

Dr. Iacone describes the incorporation of iPSC-derived iCell® and MyCell® Cardiomyocytes into their research program in diabetic cardiomyopathy associated with Type II diabetes and how these cells may enable development of personalized medicine.

4 of 108 Page ... 4 5 6  ... Next 

Popular tags in SelectScience

Buying guides